NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Nordic-Baltic Bifurcation Study IV

Active Not RecruitingNA

Sponsor: Evald Hoej Christiansen

Conditions: Coronary Artery Disease

Interventions: Implantation of coronary stent in bifurcation lesion, Implantation of coronary stent in bifurcation lesion

Countries: Denmark

How should coronary artery stenoses with significant side branch be stented? A strategy of stenting both main vessel and side branch compared to a strategy of stenting the main vessel and only stenting the side branch if necessary. The 2-stent strategy is superior to the 1-stent strategy regarding occurrence of cardiac death, non-procedure related myocardial infarction and re-revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Stable or unstable angina pectoris or silent angina pectoris.
* Genuine bifurcation lesion ( Medina type 1,1,1 or 1,0,1 or 0,1,1)
* Lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA-PDA/posterolateral branch" or "LM/Cx/LAD".
* Diameter of main vessel by visual estimate \>3.0 mm.
* Diameter of side branch by visual estimate \>2.75 mm.
* Signed informed consent.

Exclusion Criteria:

* ST-elevation infarction within 24 hours.
* Side branch lesion length \>15 mm.
* Expected survival \< 1 year.
* S-creatinine \>200 µmol/l.
* Allergy to Aspirin, Clopidogrel or Ticlopidine.
* Allergy to Sirolimus.

Locations (1)

Skejby, Aarhus N, Denmark